Research map: Empowering Clinical Development With Disease Progression Modeling: Recommendations From the Clinical Trials Transformation Initiative

Back to the article

Papers in this map

  1. Sharing Clinical Trial Data · Bernard Lo · 2015 · 238 citations · Cited by this paper
  2. Device and Data Access Considerations for Digital Health Studies Using Consumer‐Grade Wearables: An Experience‐Based Tutorial · 2026 · Related
  3. Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug Development · Y Wang · 2009 · 232 citations · Cited by this paper
  4. The Utility of Modeling and Simulation in Drug Development and Regulatory Review · Shiew-Mei Huang · 2013 · 206 citations · Cited by this paper
  5. Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation · Colleen Kuemmel · 2019 · 178 citations · Cited by this paper
  6. The future is now: Model‐based clinical trial design for Alzheimer's disease · Klaus Romero · 2014 · 82 citations · Cited by this paper
  7. Machine Learning in Modeling Disease Trajectory and Treatment Outcomes: An Emerging Enabler for Model‐Informed Precision Medicine · Nadia Terranova · 2023 · 76 citations · Cited by this paper
  8. Quantitative Systems Pharmacology: A Case for Disease Models · CJ Musante · 2016 · 73 citations · Cited by this paper
  9. Model‐based clinical drug development in the past, present and future: a commentary · Holly H. C. Kimko · 2014 · 61 citations · Cited by this paper
  10. Quantitative Systems Pharmacology: A Regulatory Perspective on Translation · Issam Zineh · 2019 · 54 citations · Cited by this paper
  11. Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets · Antii Jekunen · 2014 · 50 citations · Cited by this paper
  12. FDA’s New Plausible Mechanism Pathway · Vinay Prasad · 2025 · 49 citations · Cited by this paper
  13. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis · Daniela J. Conrado · 2017 · 48 citations · Cited by this paper
  14. Toward Good Simulation Practice · Marco Viceconti · 2024 · 47 citations · Cited by this paper
  15. Integrating Model‐Informed Drug Development With AI : A Synergistic Approach to Accelerating Pharmaceutical Innovation · Karthik Raman · 2025 · 38 citations · Cited by this paper
  16. Priorities for a New FDA · Martin A. Makary · 2025 · 36 citations · Cited by this paper
  17. One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma · Vinay Prasad · 2026 · 36 citations · Cited by this paper
  18. A Prototype QSP Model of the Immune Response to SARS‐CoV‐2 for Community Development · Wei Dai · 2020 · 33 citations · Cited by this paper
  19. Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost · Vaishali Sahasrabudhe · 2025 · 32 citations · Cited by this paper
  20. Characteristics of available studies and dissemination of research using major clinical data sharing platforms · Enrique Vázquez · 2021 · 30 citations · Cited by this paper
  21. The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway · Rajanikanth Madabushi · 2024 · 30 citations · Cited by this paper
  22. Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy · Karthik Lingineni · 2021 · 28 citations · Cited by this paper
  23. Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial · Lena Klopp‐Schulze · 2024 · 24 citations · Cited by this paper
  24. The Clinical Trials Transformation Initiative: Methodology supporting the mission · Amy L. Corneli · 2018 · 23 citations · Cited by this paper
  25. Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB · Samira Jamalian · 2023 · 22 citations · Cited by this paper
  26. Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism · Manoj Khurana · 2018 · 19 citations · Cited by this paper
  27. Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo · Karthik Venkatakrishnan · 2022 · 19 citations · Cited by this paper
  28. Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder · Shamir N. Kalaria · 2021 · 18 citations · Cited by this paper
  29. Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG) · Anna I. Scott · 2023 · 12 citations · Cited by this paper
  30. Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo ( Standard‐of‐Care ) data to enable model‐informed drug development · Kosalaram Goteti · 2022 · 11 citations · Cited by this paper
  31. Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective · Kosalaram Goteti · 2023 · 9 citations · Cited by this paper
  32. State‐of‐the‐Art on Model‐Informed Drug Development Approaches for Pediatric Rare Diseases · Rajesh Krishna · 2025 · 9 citations · Cited by this paper
  33. Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial · Siddharth Mehrotra · 2016 · 6 citations · Cited by this paper
  34. Model‐Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate‐to‐Severe Ulcerative Colitis · Jessica Wojciechowski · 2024 · 5 citations · Cited by this paper
  35. A novel machine learning based framework for developing composite digital biomarkers of disease progression · Song Zhai · 2025 · 5 citations · Cited by this paper
  36. The Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making · Summer Starling · 2024 · 4 citations · Cited by this paper
  37. Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer · Maddalena Centanni · 2025 · 3 citations · Cited by this paper
  38. A Model‐Based Meta‐Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis Trials · Jean Carlos Serrano · 2025 · 3 citations · Cited by this paper
  39. When Learn/Confirm Leads to Expand/Understand: The Expanding Role of Quantitative Systems Pharmacology in the Betterment of Therapeutics Development · Matthew M. Riggs · 2018 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)